Intensified or accelerated dosing regimens with infliximab (Remicade) did not improve outcomes compared with the standard regimen in patients with steroid-refractory acute severe ulcerative colitis ...
INCHEON, South Korea--(BUSINESS WIRE)--Celltrion today announced two-year results of subcutaneous infliximab (CT-P13 SC) dose escalation therapy at United European Gastroenterology (UEG) Week 2024 in ...
Biologic medications help reduce inflammation in ulcerative colitis. If you're new to biologics, infliximab might be your first option for ulcerative colitis. Humira lets you take your medication at ...
Please provide your email address to receive an email when new articles are posted on . Severe disability and all-cause mortality were lower at 6 months among patients given infliximab. No ...